UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Drugs & aging, ISSN 1170-229X, 2003, Volume 20, Issue 12, pp. 917 - 918
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. e484 - e492
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Immunohistochemistry | Life Style | Prognosis | Age Factors | Early Detection of Cancer - methods | Risk Reduction Behavior | Biomarkers, Tumor - analysis | Humans | Middle Aged | Risk Factors | Male | Prostatic Neoplasms - diagnosis | Evidence-Based Medicine | Prostate-Specific Antigen - blood | Prostatic Neoplasms - therapy | Neoplasm Invasiveness - pathology | Primary Prevention - methods | Aged, 80 and over | Aged | Biopsy, Needle | Prostatic Neoplasms - prevention & control | Prevention | Diagnosis | Prostate cancer | Cancer | Index Medicus | prostate cancer | risk factors | screening | prevention | PSA | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Nature genetics, ISSN 1061-4036, 07/2018, Volume 50, Issue 7, pp. 928 - 936
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Genetic Predisposition to Disease | Prostatic Neoplasms - genetics | Humans | Genotype | Male | Risk | Polymorphism, Single Nucleotide | Genetic Loci | Genome-Wide Association Study - methods | Case-Control Studies | Case studies | Genome-wide association studies | Usage | Men | Genetic aspects | Health aspects | Prostate cancer | Risk factors | Genealogy | Data processing | Mapping | Genomes | Biology | Family medical history | Loci | Meta-analysis | Confidence intervals | Consortia | Signal transduction | Software | Gene mapping | Health risk assessment | Prostate | Genotypes | Cancer | Index Medicus | Medicin och hälsovetenskap
Journal Article
The New England journal of medicine, ISSN 0028-4793, 12/2003, Volume 349, Issue 25, pp. 2387 - 2398
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Enzyme Inhibitors - adverse effects | Severity of Illness Index | Double-Blind Method | Humans | Middle Aged | 5-alpha Reductase Inhibitors | Adrenergic alpha-Antagonists - therapeutic use | Male | Prostatic Hyperplasia - classification | Enzyme Inhibitors - therapeutic use | Disease Progression | Prostatic Hyperplasia - surgery | Finasteride - adverse effects | Adrenergic alpha-Antagonists - adverse effects | Analysis of Variance | Doxazosin - therapeutic use | Finasteride - therapeutic use | Doxazosin - adverse effects | Drug Therapy, Combination | Prostatic Hyperplasia - drug therapy | Evaluation | Doxazosin | Finasteride | Drug therapy | Prostate | Hypertrophy | Clinical trials | Prostate cancer | Urogenital system | Older people | Men | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 11/2019, Volume 20, Issue 11, pp. e608 - e608
Journal Article
Cancer, ISSN 0008-543X, 02/2017, Volume 123, Issue 4, pp. 592 - 599
prostate‐specific antigen (PSA) | digital rectal examination (DRE) | prostate cancer | screening | randomized trial | prostate-specific antigen (PSA) | Life Sciences & Biomedicine | Oncology | Science & Technology | Prostatic Neoplasms - pathology | American Cancer Society | Follow-Up Studies | Early Detection of Cancer | Humans | Middle Aged | Prostatic Neoplasms - blood | Male | Aged | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Care and treatment | Patient outcomes | Analysis | Clinical trials | Outcome and process assessment (Health Care) | Diagnosis | Research | Prostate cancer | Intervention | Ovarian carcinoma | Prostate-specific antigen | Mortality | Lung cancer | Medical screening | Ovarian cancer | Confidence intervals | Screening | Randomization | Rectum | Men | Death | Fatalities | Health risk assessment | Prostate | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Cancer epidemiology, biomarkers & prevention, ISSN 1055-9965, 03/2009, Volume 18, Issue 3, pp. 748 - 751
cancer screening | hemodilution | body mass index | obesity | prostate-specific antigen | Oncology | Public, Environmental & Occupational Health | Life Sciences & Biomedicine | Science & Technology | Obesity | Biological and medical sciences | Metabolic diseases | Medical sciences | Tumors | Body Mass Index | Obesity - complications | Humans | Middle Aged | Male | Chi-Square Distribution | Obesity - blood | Prostate-Specific Antigen - blood | Mass Screening | Analysis of Variance | Prostatic Neoplasms - blood | Hemodilution | Surveys and Questionnaires | Aged | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2009, Volume 360, Issue 13, pp. 1310 - 1319
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | General aspects | Medical sciences | Epidemiology | United States - epidemiology | Follow-Up Studies | Humans | Middle Aged | Male | Prostatic Neoplasms - diagnosis | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Incidence | Prostatic Neoplasms - epidemiology | Mass Screening - adverse effects | Digital Rectal Examination - adverse effects | Aged | Patient Compliance | Medical screening | Prostate cancer | Mortality | Age | Men | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 02/2011, Volume 29, Issue 4, pp. 355 - 361
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Tumors | Predictive Value of Tests | Prognosis | Risk Assessment | Comorbidity | United States | Humans | Middle Aged | Risk Factors | Male | Unnecessary Procedures | Prostatic Neoplasms - diagnosis | Chi-Square Distribution | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Mass Screening | Time Factors | Survival Analysis | Surveys and Questionnaires | Aged | Index Medicus | Original Reports | Guc3 | Guc4 | Guc1 | Guc2
Journal Article